LENZ Therapeutics, Inc. (LENZ)

CIK 1815776 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for LENZ Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 2026SCHEDULE 13G/A0000315066-26-002766
Nov 4, 2026SCHEDULE 13G0001373604-26-000076
Nov 3, 202610-Q0001815776-26-000059
Nov 3, 202640001706176-26-000007
Nov 2, 2026SCHEDULE 13D/A0001346824-26-000251
Nov 2, 202640001231919-26-001526
Oct 28, 20268-K0001815776-26-000056
Oct 27, 2026SCHEDULE 13G0002052113-26-001098
Oct 21, 2026SCHEDULE 13G/A0001104659-26-117887
Sep 8, 2026SCHEDULE 13G/A0000315066-26-002292
Aug 11, 202610-Q0001815776-26-000052
Aug 11, 20268-K0001815776-26-000051
Jul 2, 20268-K0001815776-26-000046
Jun 26, 2026SCHEDULE 13G0001104659-26-078313
Jun 15, 202640001340881-26-000001
Jun 15, 202640001231919-26-000640
Jun 15, 202640001200889-26-000001
Jun 15, 202640001816523-26-000005
Jun 15, 202640001796789-26-000004
Jun 15, 202640001825009-26-000001
Jun 15, 202640001297491-26-000001
Jun 12, 20268-K0001815776-26-000041
May 11, 202610-Q0001815776-26-000037
May 11, 20268-K0001815776-26-000035
Apr 28, 2026ARS0001815776-26-000029